Neurologic features and genotype‐phenotype correlation in Wolfram syndrome
- 28 December 2010
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 69 (3), 501-508
- https://doi.org/10.1002/ana.22160
Abstract
Objective Wolfram syndrome (WS) is a rare neurodegenerative disorder characterized by juvenile‐onset diabetes mellitus and optic atrophy. Our aim was to describe the nature and the frequency of the neurologic manifestations, which had been poorly studied until now. Methods We performed a detailed clinical study with genotype‐phenotype correlation in a series of 59 patients with WS. Results The onset of neurologic symptoms, with a median age of 15 years, was much earlier than previously reported. Cognitive impairment, which was not frequent in previous reports, was observed in 32% of patients with neurologic signs. Like epilepsy, it was mainly found in patients who developed neurologic signs before 15 years of age. In contrast to previous series, we also found malformations of cortical development on magnetic resonance imaging in epileptic children and white matter involvement, including diffuse leukoencephalopathy, in adult patients. We identified 109 mutated alleles corresponding to 56 different mutations of the WFS1 gene, among which 10 were novel. Homozygosity or compound heterozygosity for missense mutation does not seem to influence the age of onset and the occurrence of neurologic complications. However, an interesting point concerns a possible correlation between the location of the mutations and the development of the neurologic manifestations. Interpretation This series concerns the largest cohort of WS patients reported to date. It illustrates the wide variety of neurologic signs in this syndrome and the necessity of rapid therapeutic coverage to improve the prognosis. Ann Neurol 2010.Keywords
This publication has 25 references indexed in Scilit:
- Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in miceGenes & Development, 2009
- Autosomal dominant transmission of diabetes and congenital hearing impairment secondary to a missense mutation in the WFS1 geneDiabetic Medicine, 2008
- A Homozygous Mutation in a Novel Zinc-Finger Protein, ERIS, Is Responsible for Wolfram Syndrome 2American Journal of Human Genetics, 2007
- WFS1 Is a Novel Component of the Unfolded Protein Response and Maintains Homeostasis of the Endoplasmic Reticulum in Pancreatic β-CellsJournal of Biological Chemistry, 2005
- Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 geneJournal of Medical Genetics, 2005
- Wolframin Expression Induces Novel Ion Channel Activity in Endoplasmic Reticulum Membranes and Increases Intracellular CalciumPublished by Elsevier BV ,2003
- Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1Human Molecular Genetics, 2001
- WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brainHuman Molecular Genetics, 2001
- Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane proteinHuman Molecular Genetics, 1998
- A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)Nature Genetics, 1998